Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Mózes FE, Lee JA, Vali Y, Alzoubi O, Staufer K, Trauner M, Paternostro R, Stauber RE, Holleboom AG, van Dijk AM, Mak AL, Boursier J, de Saint Loup M, Shima T, Bugianesi E, Gaia S, Armandi A, Shalimar, Lupșor-Platon M, Wong VW, Li G, Wong GL, Cobbold J, Karlas T, Wiegand J, Sebastiani G, Tsochatzis E, Liguori A, Yoneda M, Nakajima A, Hagström H, Akbari C, Hirooka M, Chan WK, Mahadeva S, Rajaram R, Zheng MH, George J, Eslam M, Petta S, Pennisi G, Viganò M, Ridolfo S, Aithal GP, Palaniyappan N, Lee DH, Ekstedt M, Nasr P, Cassinotto C, de Lédinghen V, Berzigotti A, Mendoza YP, Noureddin M, Truong E, Fournier-Poizat C, Geier A, Martic M, Tuthill T, Anstee QM, Harrison SA, Bossuyt PM, Pavlides M; LITMUS investigators. Mózes FE, et al. Among authors: gaia s. Lancet Gastroenterol Hepatol. 2023 Aug;8(8):704-713. doi: 10.1016/S2468-1253(23)00141-3. Epub 2023 Jun 5. Lancet Gastroenterol Hepatol. 2023. PMID: 37290471 Free article.
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Pennisi G, Enea M, Falco V, Aithal GP, Palaniyappan N, Yilmaz Y, Boursier J, Cassinotto C, de Lédinghen V, Chan WK, Mahadeva S, Eddowes P, Newsome P, Karlas T, Wiegand J, Wong VW, Schattenberg JM, Labenz C, Kim W, Lee MS, Lupsor-Platon M, Cobbold JFL, Fan JG, Shen F, Staufer K, Trauner M, Stauber R, Nakajima A, Yoneda M, Bugianesi E, Younes R, Gaia S, Zheng MH, Cammà C, Anstee QM, Mózes FE, Pavlides M, Petta S. Pennisi G, et al. Among authors: gaia s. Hepatology. 2023 Jul 1;78(1):195-211. doi: 10.1097/HEP.0000000000000351. Epub 2023 Mar 17. Hepatology. 2023. PMID: 36924031
Pancreatic leiomyosarcoma: EUS findings of an uncommon pancreatic mass (with video).
Gesualdo M, Bertetti NS, Mortara U, Maletta F, Moro F, Sacco M, Bruno M, De Angelis CG, Gaia S. Gesualdo M, et al. Among authors: gaia s. Endosc Ultrasound. 2023 Sep-Oct;12(5):435-436. doi: 10.1097/eus.0000000000000037. Epub 2023 Oct 23. Endosc Ultrasound. 2023. PMID: 37969164 Free PMC article. No abstract available.
The Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound Connection: Unity Is Strength, or the Endoscopic Ultrasonography Retrograde Cholangiopancreatography Concept.
De Angelis CG, Dall'Amico E, Staiano MT, Gesualdo M, Bruno M, Gaia S, Sacco M, Fimiano F, Mauriello A, Dibitetto S, Canalis C, Stasio RC, Caneglias A, Mediati F, Rocca R. De Angelis CG, et al. Among authors: gaia s. Diagnostics (Basel). 2023 Oct 20;13(20):3265. doi: 10.3390/diagnostics13203265. Diagnostics (Basel). 2023. PMID: 37892086 Free PMC article. Review.
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.
Caviglia GP, Abate ML, Troshina G, Carucci P, Rolle E, Risso A, Burlone ME, Albè A, Crevola M, Musso EC, Rosso C, Armandi A, Olivero A, Minisini R, Saracco GM, Bugianesi E, Pirisi M, Ciancio A, Gaia S. Caviglia GP, et al. Among authors: gaia s. Biology (Basel). 2023 Jan 7;12(1):94. doi: 10.3390/biology12010094. Biology (Basel). 2023. PMID: 36671786 Free PMC article.
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
Nicolosi A, Gaia S, Risso A, Rosso C, Rolle E, Abate ML, Olivero A, Armandi A, Ribaldone DG, Carucci P, Fagoonee S, Pellicano R, Saracco GM, Bugianesi E, Caviglia GP. Nicolosi A, et al. Among authors: gaia s. Minerva Gastroenterol (Torino). 2022 Dec;68(4):378-386. doi: 10.23736/S2724-5985.21.03006-0. Epub 2022 Oct 12. Minerva Gastroenterol (Torino). 2022. PMID: 36222678
Recurrent diverticulitis after elective surgery.
Giulio M, Gaia S, Andrea C, Giacomo C, Angela P, Dario M, Isacco M. Giulio M, et al. Among authors: gaia s. Int J Colorectal Dis. 2022 Oct;37(10):2149-2155. doi: 10.1007/s00384-022-04248-x. Epub 2022 Sep 1. Int J Colorectal Dis. 2022. PMID: 36048197
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease.
Caviglia GP, Nicolosi A, Abate ML, Carucci P, Rosso C, Rolle E, Armandi A, Aneli S, Olivero A, Risso A, Ribaldone DG, Fermer C, Saracco GM, Gaia S, Bugianesi E. Caviglia GP, et al. Among authors: gaia s. Curr Oncol. 2022 Jul 31;29(8):5457-5465. doi: 10.3390/curroncol29080431. Curr Oncol. 2022. PMID: 36005169 Free PMC article.
76 results